Physician Wealth Advisors’s Seres Therapeutics MCRB Stock Holding History

Physician Wealth Advisors’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-142	Closed	-$1.26K	–	2408
2026 Q1	$1.26K	Hold	142	–	–	﹤0.01%	1555
2025 Q4	$2.11K	Hold	142	–	–	﹤0.01%	1272
2025 Q3	$2.73K	Hold	142	–	–	﹤0.01%	1095
2025 Q2	$1.58K	Buy	+142	New	+$1.25K	﹤0.01%	1151

Other funds holding MCRB

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

RIAS

Rachor Investment Advisory Services Linden, Michigan $203M AUM

WTC

WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

Physician Wealth Advisors's MCRB Position: Q2 2026 in Review

Physician Wealth Advisors sold out of Seres Therapeutics (MCRB) in Q2 2026, closing a stake of 142 shares — an estimated $1.26K sold.

Physician Wealth Advisors first reported a position in MCRB in Q2 2025 and held it in 4 quarters. The position peaked at $2.73K in Q3 2025. 4 funds tracked by Wall St. Rank hold MCRB as of Q2 2026.

Physician Wealth Advisors reported no remaining Seres Therapeutics position as of Q2 2026 after selling out during the quarter.
Physician Wealth Advisors sold 142 Seres Therapeutics shares in Q2 2026, an estimated $1.26K.
Physician Wealth Advisors first reported a position in Seres Therapeutics in Q2 2025 and held it in 4 quarters.
Physician Wealth Advisors's Seres Therapeutics position peaked at $2.73K in Q3 2025.
4 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.